startups

10+ articles

AI AI startups AI transformation AI trends Anthropic

Stanford Students Betting on AI Startups Over Degrees

Stanford students are hitting pause on degrees, diving into AI startups. Economics professor Nicholas Bloom likens this to a new gold rush, driven by high startup valuations and the allure of shaping AI's future. It's a bet with a safety net: return to studies if ventures flop.

Apr 28

Stanford Students Betting on AI Startups Over Degrees

India's Chance to Shine Amidst Global Tech Layoffs

Global tech layoffs have exceeded 73,000 jobs in Q1 2026, marking the fastest rate since the pandemic. For India, it's a potential turning point. With tech talent streaming back home, the nation could finally retain its engineers and build world-class tech firms instead of losing talent to the West.

Apr 23

India's Chance to Shine Amidst Global Tech Layoffs

Elon Musk to Keep Control of SpaceX After IPO

Elon Musk and insiders will maintain control over SpaceX's voting shares even after the company's anticipated IPO, as per the latest filing. This move keeps Musk's influence intact, making it crucial for builders to watch how this unfolds in the market.

Apr 21

Elon Musk to Keep Control of SpaceX After IPO

AI Startups Disrupt Gaming Giants: Real-Time Pricing & Personalization

AI-driven startups are reshaping the online gaming industry by leveraging algorithms for dynamic pricing and hyper-personalized experiences. They're targeting inefficiencies between players and publishers, taking on traditional giants like Steam and Epic with real-time solutions.

Apr 21

AI Startups Disrupt Gaming Giants: Real-Time Pricing & Personalization

Toronto Startup Biossil Uses AI to Revive Failed Drugs with Peter Thiel's Backing

Peter Thiel and OpenAI back Toronto's Biossil, a startup using AI to give new purposes to failed drugs. With CAD $12M in seed funding, Biossil's "DrugRevive" platform leverages AI to cut drug repurposing time by 70-80%, bringing shelved therapies to trial faster. Promising early results include an oncology drug repurposed for a neurological disorder, now in Phase 2 trials.

Apr 20

Toronto Startup Biossil Uses AI to Revive Failed Drugs with Peter Thiel's Backing

Failed Startups' Data Fuels AI Growth, Raises Privacy Concerns

AI developers are buying data from failed startups, like Slack chats and source code, to train models. This raises privacy concerns about using identifiable internal communications. With SimpleClosure processing deals from $10,000 to $100,000, this trend reshapes AI data sourcing.

Apr 19

Failed Startups' Data Fuels AI Growth, Raises Privacy Concerns

Google CEO Pichai Sheds Light on Startups' AI Gold Rush

Sundar Pichai, Google's CEO, highlights the vast opportunities the AI transformation brings for startups and investors, likening it to past tech booms. Google is making strategic investments in AI startups through funds like Gradient Ventures to fuel entrepreneurial growth. Collaboration across big tech and startups is seen as vital to accelerating AI's integration into various sectors.

Apr 7

Google CEO Pichai Sheds Light on Startups' AI Gold Rush

AI: The Future of Work is Here, and It's Not What You Think!

AI's impact on the job market has been pronounced, yet it's not causing mass unemployment. The Asia Times explores how AI is reshaping roles, boosting productivity, and influencing labor culture—particularly through the rise of adaptable 'salarymen' and specialists. Discover how this tech revolution might shift the landscape without obliterating jobs.

Apr 7

AI: The Future of Work is Here, and It's Not What You Think!

Anthropic Restructures Claude AI Access, Ditches Third-Party Tools Like OpenClaw

In a bid to manage resource usage and costs, Anthropic has revamped access rules for its Claude AI, blocking third-party tools like OpenClaw from utilizing subscription limits and enforcing pay-per-use API billing. The change, spurred by rising costs from external usage, especially by startups, aligns Anthropic's strategy with industry practices of direct API charging. Starting with OpenClaw, this policy will expand to other third-party tools, creating ripples of reactions from developers and startups adjusting to the new economic model.

Apr 4

Anthropic Restructures Claude AI Access, Ditches Third-Party Tools Like OpenClaw

Anthropic Goes Big on Biotech: Snags Coefficient Bio for a Cool $400 Million!

In a strategic move that underscores the intersection of AI and biotechnology, Anthropic has acquired Coefficient Bio, an AI biotech startup, for approximately $400 million. This significant acquisition bolsters Anthropic's efforts to integrate artificial intelligence solutions into the biotech sector, particularly in drug discovery and life sciences applications.

Apr 3

Anthropic Goes Big on Biotech: Snags Coefficient Bio for a Cool $400 Million!